healthdata.az.govhealthdata.az.gov/az_edits/acr_v180_d1_descriptions.pdf · arizona cancer registry...

Arizona Cancer Registry

NAACCR EDITS DETAIL REPORT

Version 18D

Arizona - State Specific Edits Metafile: ACR_v180_D1

Released July 09, 2020

Arizona Cancer Registry – State Specific Edits: ACR_v180_D1.smf as of 07/09/2020

Page 2 of 1657

Arizona Cancer Registry

Summary of Changes ACR NAACCR v18 Metafile (07/09/2020=803 EDITS)

Edit Name Edit Tag AZ Edit

Filename Added Removed

AZ State Specific Edits Version created from NAACCR v18D ACR_v180_D1 6/17/2020 Orig file: https://naaccr.org/wp-content/uploads/2019/09/

NAACCR_v18D_20190902.zip

Patch 1 V18D (Updated 10/08/2019) ACR_v180_D1 6/17/2020 https://www.naaccr.org/wp-content/uploads/2019/10/

Patch-1-NAACCR_v18D_20191008-5.zip

Autopsy Only, RX, Schema ID (NPCR) N5020 ACR_v180_D1 6/17/2020

Brain Molecular Markers, Summary Stage 2018 (NAACCR) N5041 ACR_v180_D1 6/17/2020

Breslow Tumor Thickness, Melanoma, Summary Stage 2018 (NAACCR) N5042 ACR_v180_D1 6/17/2020

ER Summary, Breast, ER Percent (NAACCR) N5032 ACR_v180_D1 6/17/2020

Date Regional Lymph Node Dissection, RX Date Surgery, CoC Flag (SEER) N6086 ACR_v180_D1 6/17/2020

ER Summary, Breast, ER Percent, CoC Flag (SEER) N6120 ACR_v180_D1 6/17/2020

Grade Clin, Grade Path (NAACCR) N5027 ACR_v180_D1 6/17/2020

Grade Pathological, Post Therapy, RX Summ--Prim Site Surg (NAACCR) N3083 ACR_v180_D1 6/17/2020

HER2 Overall Summary, Breast, IHC, ISH (NAACCR) N5034 ACR_v180_D1 6/17/2020

HER2 Overall Summary, Breast, IHC, ISH, CoC Flag (SEER) N6122 ACR_v180_D1 6/17/2020

Histologic Type ICDO3, Primary Site, Date of Diagnosis (NAACCR) N4911* ACR_v180_C1 4/5/2019

Histologic Type ICDO3, Solid Tumor Rules (NAACCR) (recoded from orig N4911*) N4911

ACR_v180_C1 4/5/2019

Lymphovascular Invasion, Penis, Summary Stage 2018 (NAACCR) N5059 ACR_v180_D1 6/17/2020

Lymphovascular Invasion, Testis, Summary Stage 2018 (NAACCR) N5060 ACR_v180_D1 6/17/2020

Morphology--Type/Behavior ICDO3 (SEER MORPH) N0218 ACR_v180_C2 7/3/2019

Morphology--Type/Behavior ICDO3 (AZ) N8504 ACR_v180_C2 7/3/2019

PR Summary, Breast, PR Percent (NAACCR) N5033 ACR_v180_D1 6/17/2020

PR Summary, Breast, PR Percent, CoC Flag (SEER) N6121 ACR_v180_D1 6/17/2020

Regional Nodes Examined (NAACCR) N1247 ACR_v180_D1 6/17/2020

Regional Nodes Examined (SEER) N0605 ACR_v180_D1 6/17/2020

Regional Nodes Examined, Date of Dx (SEER) N2357 ACR_v180_D1 6/17/2020

Regional Nodes Positive (NAACCR) N1248 ACR_v180_D1 6/17/2020

Regional Nodes Positive (SEER) N0606 ACR_v180_D1 6/17/2020

Regional Nodes Positive, Date of Dx (SEER) N2358 ACR_v180_D1 6/17/2020

RX Coding System--Current (COC) N0585 ACR_v180_C2 7/3/2019

RX Coding System--Current (NAACCR) N0070 ACR_v180_C2 7/3/2019

RX Hosp--Scope Reg LN Sur, Schema ID (COC) N5024 ACR_v180_D1 6/17/2020


Page 3 of 1657

RX Hosp--Surg Prim Site, Schema ID, Primary Site (COC) N5023 ACR_v180_D1 6/17/2020

RX Summ--Scope Reg LN Sur, Schema ID (NAACCR) N5019 ACR_v180_D1 6/17/2020

RX Summ--Surg Prim Site, Schema ID, Primary Site (COC) N5015 ACR_v180_D1 6/17/2020

RX Summ--Surgical Margins, Schema ID (NAACCR) N5018 ACR_v180_D1 6/17/2020

RX Summ--Treatm Stat, Treatment (NAACCR) N5025 ACR_v180_D1 6/17/2020

RX Summ--Treatm Stat, Treatment, Blanks (NAACCR) N6065 ACR_v180_D1 6/17/2020

Sentinel Lymph Nodes Ex, Reg Nodes Ex, Date RLN Dissection (COC) N2836 ACR_v180_D1 6/17/2020

Summary Stage 2018, Behavior Code ICDO3 (NAACCR) N5000 ACR_v180_D1 6/17/2020

Summary Stage 2018, Regional Nodes Positive (NAACCR) N6104 ACR_v180_D1 6/17/2020

Surgery Rad, Phase I Rad Surg (SEER) N4929 ACR_v180_D1 6/17/2020

Surgery, RX Date Surgery, Schema ID (COC) N5021 ACR_v180_D1 6/17/2020

Tumor Size 998, Schema ID (NAACCR) N6129 ACR_v180_D1 6/17/2020

Tumor Size 999, Schema ID (NAACCR) N6130 ACR_v180_D1 6/17/2020

AZ State Specific Edits Version created from NAACCR v18C ACR_v180_C1 4/5/2019

Orig file: https://www.naaccr.org/standard-data-edits/ NAACCR_v18C_20190405.smf

AZ State Specific Edits Version created from NAACCR v18B ACR_v180_B1 10/5/2018 Orig file: https://www.naaccr.org/standard-data-edits/

NAACCR_v18B_20181005_release.smf


Page 4 of 1657

Table of Contents

Summary of Changes ................................................................................................................................................. 2 Table of Contents ...................................................................................................................................................... 4 Abstracted By (COC) ................................................................................................................................................ 21 Accession Number, Class of Case, Seq Number (COC) ............................................................................................ 22 Accession Number--Hosp (COC) .............................................................................................................................. 24 Addr at DX--City (NAACCR) ...................................................................................................................................... 25 Addr at DX--Country, Date of Diagnosis (COC) ........................................................................................................ 26 Addr at DX--Country, State (NAACCR) ..................................................................................................................... 28 Addr at DX--No/Street (NAACCR) ............................................................................................................................ 29 Addr at DX--Postal Code (NAACCR) ......................................................................................................................... 30 Addr at DX--Postal Code, Addr at DX--State (COC) .................................................................................................. 31 Addr at DX--State (NAACCR) .................................................................................................................................... 33 Addr at DX--State, Postal Code Range (NAACCR) .................................................................................................... 35 Addr at DX--Supplementl (COC) .............................................................................................................................. 38 Addr Current--City (COC) ......................................................................................................................................... 39 Addr Current--City, Date of Diagnosis (COC) ........................................................................................................... 40 Addr Current--Country, State (NAACCR) ................................................................................................................. 41 Addr Current--No/Street (COC) ............................................................................................................................... 42 Addr Current--Postal Code (COC) ............................................................................................................................ 43 Addr Current--Postal Code, Addr Current--State (COC) .......................................................................................... 44 Addr Current--State (COC) ....................................................................................................................................... 46 Age at Diagnosis (SEER AGEDX) ............................................................................................................................... 48 Age, Birth Date, Date of Diagnosis (NAACCR IF13) .................................................................................................. 49 Age, Histologic Type, COD, ICDO3 (SEER IF43) ........................................................................................................ 51 Age, Primary Site, Morph ICDO3--Adult (SEER) ....................................................................................................... 52 Age, Primary Site, Morph ICDO3--Pediatric (NPCR) ................................................................................................ 55 Age, Primary Site, Morphology ICDO3 (SEER IF15) ................................................................................................. 61 Autopsy Only, RX (NPCR) ......................................................................................................................................... 65 Autopsy Only, RX, Schema ID (NPCR) ...................................................................................................................... 68 Behav ICDO3, Date of DX, ICDO3 Conv Flag (SEER IF87) ......................................................................................... 71 Behavior Code ICDO3, Sequence Number--Hosp (COC).......................................................................................... 73 Behavior ICDO3 (COC) ............................................................................................................................................. 75 Behavior ICDO3 Conversion (NAACCR) ................................................................................................................... 76 Behavior ICDO3, Date of Diagnosis (NAACCR) ........................................................................................................ 77 Behavior ICDO3, Summary Stage 1977 (NAACCR) .................................................................................................. 78 Behavior ICDO3, Summary Stage 2000 (NAACCR) .................................................................................................. 79 Birthplace--Country (COC) ....................................................................................................................................... 80 Birthplace--Country (NAACCR) ................................................................................................................................ 82 Birthplace--Country, Birthplace--State (NAACCR) ................................................................................................... 83 Birthplace--Country, Date of Diagnosis (COC) ......................................................................................................... 85 Birthplace--Country, Date of Diagnosis (NAACCR) .................................................................................................. 87 Birthplace--State (COC) ........................................................................................................................................... 89 Birthplace--State (NAACCR) ..................................................................................................................................... 90 Birthplace--State, Date of Diagnosis (COC) ............................................................................................................. 91 Birthplace--State, Date of Diagnosis (NAACCR) ....................................................................................................... 93 Bladder, RX Hosp--Surg Prim Site, BRM (COC) ........................................................................................................ 94 Bladder, RX Summ--Surg Prim Site, BRM (COC) ...................................................................................................... 95


Page 5 of 1657

Brain Molecular Markers, Date DX (NAACCR) ......................................................................................................... 96 Brain Molecular Markers, Morph--Type&Behav ICD-O-3 (NAACCR) ...................................................................... 98 Brain Molecular Markers, Schema ID, Required (NAACCR) .................................................................................. 100 Brain Molecular Markers, Summary Stage 2018 (NAACCR) .................................................................................. 102 Breslow Tumor Thickness, Date DX (NAACCR) ...................................................................................................... 103 Breslow Tumor Thickness, Melanoma, Behavior (NAACCR) ................................................................................. 105 Breslow Tumor Thickness, Melanoma, Summary Stage 2018 (NAACCR) ............................................................. 107 Breslow Tumor Thickness, Schema ID, Required (NAACCR) ................................................................................. 108 Cancer Status (COC) ............................................................................................................................................... 110 Casefinding Source (NAACCR) ............................................................................................................................... 111 Cause of Death (SEER COD) ................................................................................................................................... 112 Class of Case (COC) ................................................................................................................................................ 113 Class of Case, Date of 1st Cont, Date of DX (COC) ................................................................................................. 114 Class of Case, Date of DX (AZ) ............................................................................................................................... 115 Class of Case, Type of Reporting Source (NAACCR) .............................................................................................. 116 Class, Date Diag, Date Last Cont, Vit Stat (COC) .................................................................................................... 117 COC Coding Sys--Curr, COC Coding Sys--Orig (COC) .............................................................................................. 118 COC Coding Sys--Current (COC) ............................................................................................................................. 119 COC Coding Sys--Original (COC) ............................................................................................................................. 120 COC Coding Sys--Original, Date of Diagnosis (COC) .............................................................................................. 121 County at DX Reported (NAACCR) ......................................................................................................................... 122 County at DX Reported, Addr at DX--State (NAACCR) ........................................................................................... 123 CS Eval Items, Class of Case (CS) ............................................................................................................................ 125 CS Eval Items, Type of Reporting Source (CS) ....................................................................................................... 127 CS Eval Items, Vital Status (CS) .............................................................................................................................. 129 CS Ext, Histol ICDO3, Breast Schema (CS) .............................................................................................................. 131 CS Ext, LN, Mets at DX, SSF 1, Retinoblastoma (CS) .............................................................................................. 134 CS Ext, LN, Mets at DX, SSF 3, Prostate (CS) .......................................................................................................... 136 CS Ext, Surg, TS/Ext Eval, Prostate (CS) ................................................................................................................. 138 CS Ext,TS/Ext Eval, SSF 1, MelanomaConjunc (CS) ................................................................................................ 140 CS Extension (CS) ................................................................................................................................................... 142 CS Extension, Brain Schema (CS) ........................................................................................................................... 143 CS Extension, CS Lymph Nodes, CS Mets at DX (CS) .............................................................................................. 145 CS Extension, CS Tumor Size, Breast Schema (CS) ................................................................................................. 148 CS Extension, CS Tumor Size, MycosisFungoides (CS) ........................................................................................... 150 CS Extension, CS Tumor Size, Site, Hist ICDO3 (CS) ............................................................................................... 152 CS Extension, Hematopoietic (CS) ......................................................................................................................... 156 CS Extension, Hist, Grade, Esophagus Schema (CS) .............................................................................................. 158 CS Extension, Hist, Grade, EsophagusGEJunction (CS) .......................................................................................... 160 CS Extension, Histology, Grade, Thyroid (CS) ........................................................................................................ 162 CS Extension, KidneyRenalPelvis Schema (CS) ...................................................................................................... 164 CS Extension, Lymphoma Schema (CS) .................................................................................................................. 166 CS Extension, Morphology, Bladder ICDO3 (CS) .................................................................................................... 168 CS Extension, Mycosis Fungoides Schema (CS) ..................................................................................................... 170 CS Extension, MyelomaPlasmaCellDisorder (CS)................................................................................................... 172 CS Extension, Primary Site, Behavior ICDO3 (CS) .................................................................................................. 174 CS Extension, Schema (CS) .................................................................................................................................... 178 CS Extension, SSF 1, Conjunctiva Schema (CS) ...................................................................................................... 180 CS Extension, SSF 1, Head and Neck Schemas (CS) ............................................................................................... 182


Page 6 of 1657

CS Extension, SSF 1, Lung Schema (CS) .................................................................................................................. 185 CS Extension, SSF 1, MelanomaConjunctiva (CS) .................................................................................................. 187 CS Extension, SSF 11, MerkelCellVulva Schema (CS) ............................................................................................. 189 CS Extension, SSF 11, Vulva Schema (CS) .............................................................................................................. 191 CS Extension, SSF 16, Scrotum Schema (CS) .......................................................................................................... 193 CS Extension, SSF 16, Skin Schema (CS) ................................................................................................................. 195 CS Extension, SSF 17, Penis Schema (CS) ............................................................................................................... 197 CS Extension, SSF 2, Bladder Schema (CS) ............................................................................................................. 199 CS Extension, SSF 2, MelanomaChoroid (CS)......................................................................................................... 201 CS Extension, SSF 2, MelanomaCiliaryBody (CS) ................................................................................................... 203 CS Extension, SSF 3, Behavior, Prostate (CS) ......................................................................................................... 205 CS Extension, SSF 3, Breast Schema (CS) ............................................................................................................... 207 CS Extension, SSF 3, MelanomaChoroid (CS)......................................................................................................... 209 CS Extension, SSF 3, MelanomaCiliaryBody (CS) ................................................................................................... 211 CS Extension, SSF 5, Testis Schema (CS) ................................................................................................................ 213 CS Extension, Surgery, Prostate Schema (CS) ........................................................................................................ 215 CS Extension, TS/Ext Eval, Prostate Schema (CS) .................................................................................................. 217 CS Extension, Tumor Size, Lung Schema (CS) ........................................................................................................ 219 CS Items - NPCR Required - Non-SSF (CS) .............................................................................................................. 221 CS Items - NPCR Required - SSF 1 (CS) - 2015 ........................................................................................................ 225 CS Items - NPCR Required - SSF 1 (CS) - 2016+ ...................................................................................................... 229 CS Items - NPCR Required - SSF 10 (CS) - 2015 ...................................................................................................... 231 CS Items - NPCR Required - SSF 10 (CS) - 2016+ .................................................................................................... 235 CS Items - NPCR Required - SSF 11 (CS) - 2015 ...................................................................................................... 237 CS Items - NPCR Required - SSF 11 (CS) - 2016+ .................................................................................................... 241 CS Items - NPCR Required - SSF 12 (CS) ................................................................................................................. 243 CS Items - NPCR Required - SSF 13 (CS) - 2015 ...................................................................................................... 247 CS Items - NPCR Required - SSF 13 (CS) - 2016+ .................................................................................................... 251 CS Items - NPCR Required - SSF 14 (CS) - 2015 ...................................................................................................... 253 CS Items - NPCR Required - SSF 14 (CS) - 2016+ .................................................................................................... 257 CS Items - NPCR Required - SSF 15 (CS) - 2015 ...................................................................................................... 260 CS Items - NPCR Required - SSF 15 (CS) - 2016+ .................................................................................................... 263 CS Items - NPCR Required - SSF 16 (CS) - 2015 ...................................................................................................... 265 CS Items - NPCR Required - SSF 16 (CS) - 2016+ .................................................................................................... 269 CS Items - NPCR Required - SSF 17 (CS) ................................................................................................................. 271 CS Items - NPCR Required - SSF 18 (CS) ................................................................................................................. 273 CS Items - NPCR Required - SSF 19 (CS) ................................................................................................................. 275 CS Items - NPCR Required - SSF 2 (CS) - 2015 ........................................................................................................ 277 CS Items - NPCR Required - SSF 2 (CS) - 2016+ ...................................................................................................... 281 CS Items - NPCR Required - SSF 20 (CS) ................................................................................................................. 283 CS Items - NPCR Required - SSF 21 (CS) ................................................................................................................. 285 CS Items - NPCR Required - SSF 22 (CS) ................................................................................................................. 287 CS Items - NPCR Required - SSF 23 (CS) ................................................................................................................. 289 CS Items - NPCR Required - SSF 24 (CS) ................................................................................................................. 291 CS Items - NPCR Required - SSF 25 (CS) - 2016+ .................................................................................................... 293 CS Items - NPCR Required - SSF 3 (CS) ................................................................................................................... 295 CS Items - NPCR Required - SSF 4 (CS) ................................................................................................................... 297 CS Items - NPCR Required - SSF 5 (CS) - 2015 ........................................................................................................ 299 CS Items - NPCR Required - SSF 5 (CS) - 2016+ ...................................................................................................... 301


Page 7 of 1657

CS Items - NPCR Required - SSF 6 (CS) - 2015 ........................................................................................................ 303 CS Items - NPCR Required - SSF 6 (CS) - 2016+ ...................................................................................................... 305 CS Items - NPCR Required - SSF 7 (CS) ................................................................................................................... 307 CS Items - NPCR Required - SSF 8 (CS) - 2015 ........................................................................................................ 309 CS Items - NPCR Required - SSF 8 (CS) - 2016+ ...................................................................................................... 313 CS Items - NPCR Required - SSF 9 (CS) - 2015 ........................................................................................................ 315 CS Items - NPCR Required - SSF 9 (CS) - 2016+ ...................................................................................................... 319 CS Items, DX Post 2017 (CS) .................................................................................................................................. 321 CS Items, DX Pre-2004 (CS) .................................................................................................................................... 324 CS Items, Type Reporting Source-DCO (CS) ........................................................................................................... 327 CS LN, Nodes Eval, SSF 3, MelanomaSkin (CS) ....................................................................................................... 333 CS LN, Nodes Eval, SSF 3, MerkelCellPenis (CS) ..................................................................................................... 335 CS LN, Nodes Eval, SSF 3, MerkelCellScrotum (CS) ................................................................................................ 337 CS LN, Nodes Eval, SSF 3, MerkelCellSkin (CS) ....................................................................................................... 339 CS LN, Nodes Eval, SSF 3, MerkelCellVulva (CS) .................................................................................................... 341 CS LN, RNP, Nodes Eval, SSF 3, MelanomaSkin (CS) .............................................................................................. 343 CS Lymph Nodes (CS) ............................................................................................................................................. 347 CS Lymph Nodes Eval (CS) ..................................................................................................................................... 348 CS Lymph Nodes Eval, Lymph Nodes, Breast Schema (CS) ................................................................................... 349 CS Lymph Nodes Eval, Nodes Ex (CS)..................................................................................................................... 351 CS Lymph Nodes Eval, Schema (CS) ....................................................................................................................... 353 CS Lymph Nodes, IntracranialGland Schema (CS) ................................................................................................. 355 CS Lymph Nodes, LN Nodes Eval, RNP, Testis (CS) ................................................................................................ 357 CS Lymph Nodes, Lymph Nodes Eval, RNP (CS) ..................................................................................................... 359 CS Lymph Nodes, MyelomaPlasmaCellDisorder (CS) ............................................................................................ 361 CS Lymph Nodes, Nodes Pos, ColoAppRectal (CS) ................................................................................................ 363 CS Lymph Nodes, Nodes Pos, MelanomaSkin (CS) ................................................................................................ 365 CS Lymph Nodes, Nodes Pos, MerkelCell Schemas (CS) ....................................................................................... 367 CS Lymph Nodes, Nodes Pos, SSF 3, Breast Schema (CS) ...................................................................................... 369 CS Lymph Nodes, Regional Nodes Positive (CS) .................................................................................................... 372 CS Lymph Nodes, Schema (CS) .............................................................................................................................. 374 CS Lymph Nodes, SSF 1, Head/Neck Schemas (CS) ............................................................................................... 376 CS Lymph Nodes, SSF 17, Penis (CS) ...................................................................................................................... 379 CS Lymph Nodes, SSF 3, Nodes Eval, MelanomaSkin (CS) ..................................................................................... 381 CS Lymph Nodes, SSF 3, Nodes Eval, MerkelCell (CS) ........................................................................................... 384 CS Lymph Nodes, SSF 4, 5, Breast Schema (CS) ..................................................................................................... 387 CS Mets at DX (CS) ................................................................................................................................................. 390 CS Mets at DX, Lung, Laterality (CS) ...................................................................................................................... 391 CS Mets at DX, Schema (CS) .................................................................................................................................. 393 CS Mets at DX, SSF 4, MelanomaChor/Cil/Iris (CS) ................................................................................................ 395 CS Mets Eval (CS) ................................................................................................................................................... 397 CS Mets Eval, Mets at DX, CS Version Inp Orig (CS) .............................................................................................. 398 CS Mets Eval, Schema (CS) .................................................................................................................................... 400 CS Over-ride CS 20, Date of Diagnosis (NPCR) ....................................................................................................... 402 CS Over-ride CS 20, Rpt Srce, CS Fields (NPCR) ..................................................................................................... 404 CS Over-rides (NPCR) ............................................................................................................................................. 407 CS Reg Nodes Ex, Pos, Site, Hist ICDO3, Report (CS) ............................................................................................. 409 CS Site-Specific Factor 1 (CS) ................................................................................................................................. 413 CS Site-Specific Factor 1, Schema (CS) ................................................................................................................... 414


Page 8 of 1657

CS Site-Specific Factor 2 (CS) ................................................................................................................................. 416 CS Site-Specific Factor 2, Schema (CS) ................................................................................................................... 417 CS Site-Specific Factor 2, Schema (SEER) ............................................................................................................... 419 CS Site-Specific Factor 3 (CS) ................................................................................................................................. 421 CS Site-Specific Factor 3, Schema (CS) ................................................................................................................... 422 CS Site-Specific Factor 3, Schema (SEER) ............................................................................................................... 424 CS Site-Specific Factor 4 (CS) ................................................................................................................................. 426 CS Site-Specific Factor 4, Schema (CS) ................................................................................................................... 427 CS Site-Specific Factor 5 (CS) ................................................................................................................................. 429 CS Site-Specific Factor 5, Schema (CS) ................................................................................................................... 430 CS Site-Specific Factor 6 (CS) ................................................................................................................................. 432 CS Site-Specific Factor 6, Schema (CS) ................................................................................................................... 433 CS Site-Specific Factor 7 (CS) ................................................................................................................................. 435 CS Site-Specific Factor 7, Schema (CS) ................................................................................................................... 436 CS Site-Specific Factor 8 (CS) ................................................................................................................................. 438 CS Site-Specific Factor 8, Schema (CS) ................................................................................................................... 439 CS Site-Specific Factor 9 (CS) ................................................................................................................................. 441 CS Site-Specific Factor 9, Schema (CS) ................................................................................................................... 442 CS Site-Specific Factor10 (CS) ................................................................................................................................ 444 CS Site-Specific Factor10, Schema (CS) ................................................................................................................. 445 CS Site-Specific Factor10, Schema (SEER) ............................................................................................................. 447 CS Site-Specific Factor11 (CS) ................................................................................................................................ 449 CS Site-Specific Factor11, Schema (CS) ................................................................................................................. 450 CS Site-Specific Factor12 (CS) ................................................................................................................................ 452 CS Site-Specific Factor12, Schema (CS) ................................................................................................................. 453 CS Site-Specific Factor13 (CS) ................................................................................................................................ 455 CS Site-Specific Factor13, Schema (CS) ................................................................................................................. 456 CS Site-Specific Factor14 (CS) ................................................................................................................................ 458 CS Site-Specific Factor14, Schema (CS) ................................................................................................................. 459 CS Site-Specific Factor15 (CS) ................................................................................................................................ 461 CS Site-Specific Factor15, Schema (CS) ................................................................................................................. 462 CS Site-Specific Factor16 (CS) ................................................................................................................................ 464 CS Site-Specific Factor16, Schema (CS) ................................................................................................................. 465 CS Site-Specific Factor17 (CS) ................................................................................................................................ 467 CS Site-Specific Factor17, Schema (CS) ................................................................................................................. 468 CS Site-Specific Factor18 (CS) ................................................................................................................................ 470 CS Site-Specific Factor18, Schema (CS) ................................................................................................................. 471 CS Site-Specific Factor19 (CS) ................................................................................................................................ 473 CS Site-Specific Factor19, Schema (CS) ................................................................................................................. 474 CS Site-Specific Factor20 (CS) ................................................................................................................................ 476 CS Site-Specific Factor20, Schema (CS) ................................................................................................................. 477 CS Site-Specific Factor21 (CS) ................................................................................................................................ 479 CS Site-Specific Factor21, Schema (CS) ................................................................................................................. 480 CS Site-Specific Factor22 (CS) ................................................................................................................................ 482 CS Site-Specific Factor22, Schema (CS) ................................................................................................................. 483 CS Site-Specific Factor23 (CS) ................................................................................................................................ 485 CS Site-Specific Factor23, Schema (CS) ................................................................................................................. 486 CS Site-Specific Factor24 (CS) ................................................................................................................................ 488 CS Site-Specific Factor24, Schema (CS) ................................................................................................................. 489


Page 9 of 1657

CS Site-Specific Factor25 (CS) ................................................................................................................................ 491 CS Site-Specific Factor25, Schema (CS) ................................................................................................................. 492 CS SSF 1, Behavior, Lung Schema (CS) ................................................................................................................... 494 CS SSF 1, Brain, CNSOther, IntracranialGland (CS) ................................................................................................ 496 CS SSF 1, CS SSF 3, Lower GI Schemas (CS) ............................................................................................................ 498 CS SSF 1, Extension, Gyn Schemas (CS) ................................................................................................................. 500 CS SSF 1, RX Summ--Surg, Retinoblastoma Schema (CS) ...................................................................................... 502 CS SSF 1, Skin/Scrotum/Merkel Cell Schemas (CS) ................................................................................................ 504 CS SSF 1, SSF 2, Prostate Schema (CS) ................................................................................................................... 506 CS SSF 1, SSF 2, SSF 15, SSF 16, Breast (CS) ........................................................................................................... 508 CS SSF 1, Surg, DX/Stg, Sarcomas (CS) ................................................................................................................... 512 CS SSF 1, Surg, Sarcomas (CS) ................................................................................................................................ 514 CS SSF 1, TS/Ext Eval, Retinoblastoma Schema (CS) .............................................................................................. 516 CS SSF 1, Upper GI Schemas (CS) ........................................................................................................................... 518 CS SSF 1-9, Head and Neck Schemas (CS) .............................................................................................................. 520 CS SSF 10, SSF 11, Breast (CS) ................................................................................................................................ 524 CS SSF 10, SSF 11, Surgery, DX/Stg, Breast (CS) ..................................................................................................... 526 CS SSF 10, SSF 16, Testis (CS) ................................................................................................................................. 528 CS SSF 11, GISTAppendix, Colon, Rectum (CS) ...................................................................................................... 530 CS SSF 11, Lip/OralCavity/Nasal Schemas (CS) ...................................................................................................... 532 CS SSF 11, Lymph Nodes, Vulva (CS) ...................................................................................................................... 534 CS SSF 11, Surg, Appendix Schema (CS)................................................................................................................. 536 CS SSF 11, Surg, DX/Stg Proc, Appendix Schema (CS) ........................................................................................... 538 CS SSF 12, SSF 13, Breast (CS) ................................................................................................................................ 540 CS SSF 12, SSF 13, Surgery, DX/Stg, Breast (CS) ..................................................................................................... 542 CS SSF 14, Surgery, DX/Stg, Breast (CS) ................................................................................................................. 544 CS SSF 15, SSF 9, 11, 13, 14, Breast (CS) ................................................................................................................ 546 CS SSF 16, Skin and Scrotum Schemas (CS) ........................................................................................................... 548 CS SSF 2, LN, LN Eval, RNP, SmallIntestine (CS) ..................................................................................................... 550 CS SSF 2, Lower GI Schemas (CS) ........................................................................................................................... 552 CS SSF 2, Lymph Nodes, Bladder (CS) .................................................................................................................... 554 CS SSF 25, PeritoneumFemaleGen (CS) ................................................................................................................. 556 CS SSF 3, Breast Schema (CS) ................................................................................................................................. 558 CS SSF 3, RX Summ--Surg, Prostate Schema (CS) .................................................................................................. 560 CS SSF 3, RX Summ--SurgMargins, Prost Schema (CS) .......................................................................................... 562 CS SSF 3, TS/Ext Eval, Prostate Schema (CS) .......................................................................................................... 564 CS SSF 4, RX Summ--Surg, Testis Schema (CS) ....................................................................................................... 568 CS SSF 5, GISTPeritoneum (CS) .............................................................................................................................. 570 CS SSF 5, Lymph Nodes, Testis (CS) ....................................................................................................................... 572 CS SSF 6, GISTEsoph, SmallIntest, Stomach (CS) ................................................................................................... 574 CS SSF 7, MelanomaSkin (CS) ................................................................................................................................ 576 CS SSF 7, SSF 13, Testis (CS) ................................................................................................................................... 578 CS SSF 8, CS SSF 9, Breast (CS) ............................................................................................................................... 580 CS SSF 8, CS SSF 9, Surgery, DX/Stg, Breast (CS) .................................................................................................... 582 CS SSF 8, SSF 10, Grade, Prostate (SEER) ............................................................................................................... 584 CS SSF 9, SSF 15, Testis (CS) ................................................................................................................................... 587 CS TS/Ext Eval, Surg/Rad Seq, Prostate (CS) .......................................................................................................... 589 CS TS/Ext Eval, Surgery, Bladder Schema (CS) ....................................................................................................... 591 CS TS/Ext Eval, Surgery, Prostate Schema (CS) ...................................................................................................... 593


Page 10 of 1657

CS TS/Ext Eval, Sys/Surg Seq, Prostate (CS) ........................................................................................................... 596 CS Tumor Size (CS) ................................................................................................................................................. 598 CS Tumor Size, Schema (CS) .................................................................................................................................. 599 CS Tumor Size, Site, Histol ICDO3 (CS) ................................................................................................................... 601 CS Tumor Size, SSF 1, MelanomaConjunctiva (CS) ................................................................................................ 603 CS Tumor Size/Ext Eval (CS) ................................................................................................................................... 605 CS Tumor Size/Ext Eval, Schema (CS) .................................................................................................................... 606 CS Validate Schema (CS) ........................................................................................................................................ 608 CS Validate Schema (NPCR) ................................................................................................................................... 610 CS Verify CStage Version 0205xx (CS) .................................................................................................................... 612 CS Version Derived (CS) ......................................................................................................................................... 613 CS Version Input Current (CS) ................................................................................................................................ 615 CS Version Input Current, CS Version Derived (CS) ............................................................................................... 617 CS Version Input Original (CS) ............................................................................................................................... 618 CS Version Input Original, CS Version Derived (CS) ............................................................................................... 620 CS Version Input Original, Version Input Curr (CS) ................................................................................................ 621 Date 1st Crs RX COC (COC) .................................................................................................................................... 622 Date 1st Crs RX COC Flag (NAACCR) ...................................................................................................................... 624 Date 1st Crs RX COC, Date Flag (NPCR) ................................................................................................................. 626 Date 1st Crs RX COC, Date Initial RX SEER (NPCR) ................................................................................................. 628 Date 1st Crs RX COC, Date of Diagnosis (COC) ...................................................................................................... 629 Date 1st Crs RX COC, Date of Last Contact (COC) .................................................................................................. 630 Date 1st Crs RX COC, Dates of RX (COC) ................................................................................................................ 631 Date Case Completed (NAACCR DATEEDIT) .......................................................................................................... 634 Date Case Completed, Date of Diagnosis (NAACCR) ............................................................................................. 635 Date Case Report Exported (NAACCR DATEEDIT) ................................................................................................. 636 Date Initial RX SEER (NAACCR) .............................................................................................................................. 637 Date Initial RX SEER Flag (NAACCR) ....................................................................................................................... 639 Date Initial RX SEER, Date Flag (NPCR) .................................................................................................................. 641 Date of 1st Contact (COC) ...................................................................................................................................... 643 Date of 1st Contact Flag (NAACCR) ....................................................................................................................... 645 Date of 1st Contact, Date Flag (NAACCR) .............................................................................................................. 646 Date of 1st Contact, Date of Inpt Disch (AZ) ......................................................................................................... 647 Date of Birth (NAACCR) ......................................................................................................................................... 649 Date of Birth Flag (NAACCR) .................................................................................................................................. 651 Date of Birth, Date Flag (NAACCR) ........................................................................................................................ 652 Date of Birth, Date of Diagnosis (NAACCR IF47) ................................................................................................... 653 Date of Diagnosis (NAACCR DATEEDIT) ................................................................................................................. 655 Date of Diagnosis Flag (NAACCR) .......................................................................................................................... 657 Date of Diagnosis, Date Flag (NAACCR) ................................................................................................................. 658 Date of Last Contact (NAACCR DATEEDIT) ............................................................................................................ 659 Date of Last Contact Flag (NAACCR) ...................................................................................................................... 661 Date of Last Contact, Date Flag (NAACCR) ............................................................................................................ 662 Date of Last Contact, Date of Diag (NAACCR IF19) ................................................................................................ 664 Date Regional Lymph Node Dissection, RX Date Surgery, CoC Flag (SEER) ........................................................... 665 Death Certificate Only, RX (NPCR) ......................................................................................................................... 666 Derived AJCC--Flag (CS) ......................................................................................................................................... 668 Derived AJCC--Flag, Derived AJCC (COC) ............................................................................................................... 669 Derived AJCC-6 M (CS) ........................................................................................................................................... 672


Page 11 of 1657

Derived AJCC-6 M Descriptor (CS) ......................................................................................................................... 673 Derived AJCC-6 N (CS) ............................................................................................................................................ 674 Derived AJCC-6 N Descriptor (CS) .......................................................................................................................... 676 Derived AJCC-6 Stage Group (CS) .......................................................................................................................... 677 Derived AJCC-6 T (CS) ............................................................................................................................................ 679 Derived AJCC-6 T Descriptor (CS) .......................................................................................................................... 681 Derived AJCC-7 M (CS) ........................................................................................................................................... 682 Derived AJCC-7 M Descriptor (CS) ......................................................................................................................... 683 Derived AJCC-7 N (CS) ............................................................................................................................................ 684 Derived AJCC-7 N Descript (CS) ............................................................................................................................. 686 Derived AJCC-7 Stage Group (CS) .......................................................................................................................... 687 Derived AJCC-7 T (CS) ............................................................................................................................................ 689 Derived AJCC-7 T Descript (CS) .............................................................................................................................. 691 Derived CS Items, Date of DX (COC) ...................................................................................................................... 692 Derived CS Items, DX Post 2017 (CS) ..................................................................................................................... 695 Derived CS Items, DX Pre-2004 (CS) ...................................................................................................................... 698 Derived SS1977 (CS) .............................................................................................................................................. 700 Derived SS1977--Flag (CS) ..................................................................................................................................... 701 Derived SS1977--Flag, Derived SS1977 (CS) .......................................................................................................... 702 Derived SS2000 (CS) .............................................................................................................................................. 703 Derived SS2000, Behavior ICDO3 (CS) ................................................................................................................... 704 Derived SS2000--Flag (CS) ..................................................................................................................................... 706 Derived SS2000--Flag, Derived SS2000 (CS) .......................................................................................................... 707 Diagnostic Confirm, Seq Num--Hosp (COC) ........................................................................................................... 708 Diagnostic Confirmation (SEER DXCONF) .............................................................................................................. 710 Diagnostic Confirmation, Behavior ICDO3 (SEER IF31) ......................................................................................... 711 Diagnostic Confirmation, Histology ICDO3 (SEER IF48) ......................................................................................... 713 Edit Over-rides (NAACCR) ...................................................................................................................................... 715 Edit Over-rides (SEER REVIEWFL) .......................................................................................................................... 717 ER Summary, Breast, ER Percent (NAACCR) .......................................................................................................... 719 ER Summary, Breast, ER Percent, CoC Flag (SEER) ................................................................................................ 720 Estrogen Receptor Summary, Date DX (NAACCR) ................................................................................................. 721 Estrogen Receptor Summary, Schema ID, Required (NAACCR) ............................................................................ 723 Fibrosis Score, Date DX (NAACCR) ......................................................................................................................... 725 Fibrosis Score, Schema ID, Required (NAACCR) .................................................................................................... 727 Follow-Up Source (COC) ........................................................................................................................................ 729 Grade (COC) ........................................................................................................................................................... 730 Grade Clin, Grade Path (NAACCR) ......................................................................................................................... 731 Grade Clin,Path,PostTX, Date of Diagnosis (NAACCR) ........................................................................................... 733 Grade Clinical (NAACCR) ........................................................................................................................................ 734 Grade Path, Grade Post Therapy (NAACCR) .......................................................................................................... 736 Grade Pathological (NAACCR) ............................................................................................................................... 737 Grade Pathological, Post Therapy, RX Summ--Prim Site Surg (NAACCR) .............................................................. 739 Grade Post Therapy (NAACCR) .............................................................................................................................. 741 Grade, Date of Diagnosis (COC) ............................................................................................................................. 743 Grade, Lymphoma Ocular Adnexa, Histologic Type ICD-O-3 (NAACCR) ................................................................ 744 Grade, Ovary/PPC/FT, Behavior ICD-O-3 (NAACCR) .............................................................................................. 746 Grade, Schema ID (NAACCR) ................................................................................................................................. 748 HER2 Overall Summary, Breast, IHC, ISH (NAACCR) .............................................................................................. 758


Page 12 of 1657

HER2 Overall Summary, Breast, IHC, ISH, CoC Flag (SEER) .................................................................................... 760 HER2 Overall Summary, Date DX (NAACCR) .......................................................................................................... 762 HER2 Overall Summary, Schema ID, Required (NAACCR) ..................................................................................... 764 Hist ICDO3, Date of DX, ICDO3 Conv Flag (SEER IF86) ........................................................................................... 766 Histologic Type ICD-O-3, Behavior, Grade (SEER).................................................................................................. 768 Histologic Type ICDO3 Conversion (NAACCR) ....................................................................................................... 770 Histologic Type ICDO3, Solid Tumor Rules (NAACCR) ........................................................................................... 771 Histology ICDO3, Date DX, Date 1st Cont (NAACCR) ............................................................................................. 774 Histology ICDO3, Grade, Date of DX (SEER)........................................................................................................... 775 ICD Revision Number (NPCR) ................................................................................................................................ 778 ICD Revision, Vital Stat, Date Last Contact (NPCR) ................................................................................................ 779 ICD-O-3 Conversion Flag (NAACCR) ....................................................................................................................... 781 ICD-O-3 Conversion Flag, Histology ICDO3 (SEER IF95) ......................................................................................... 782 Laterality (SEER LATERAL) ...................................................................................................................................... 783 Laterality, Primary Site (COC) ................................................................................................................................ 784 LDH Pretreatment Lab Value, Date DX (NAACCR) ................................................................................................. 787 LDH Pretreatment Lab Value, Schema ID, Required (NAACCR) ............................................................................ 789 Lymphoma ICDO3, Site, Summ Stg 1977 (NAACCR) .............................................................................................. 791 Lymphovascular Invasion (COC) ............................................................................................................................ 792 Lymphovascular Invasion (CS) ............................................................................................................................... 793 Lymphovascular Invasion, Date of Dx (SEER) ........................................................................................................ 794 Lymphovascular Invasion, Histology, Behav (CS) .................................................................................................. 796 Lymphovascular Invasion, Penis and Testis (CS) ................................................................................................... 798 Lymphovascular Invasion, Penis, Summary Stage 2018 (NAACCR) ....................................................................... 800 Lymphovascular Invasion, Schema ID (COC) ......................................................................................................... 801 Lymphovascular Invasion, Testis, Summary Stage 2018 (NAACCR) ...................................................................... 805 Marital Status at DX (SEER MARITAL) .................................................................................................................... 807 Marital Status at DX, Age at Diagnosis (SEER IF14) ............................................................................................... 808 Medical Record Number (COC) ............................................................................................................................. 810 Microsatellite Instability (MSI), Date DX (NAACCR) .............................................................................................. 811 Microsatellite Instability (MSI), Schema ID, Required (NAACCR) .......................................................................... 813 Morph Coding Sys--Curr, Morph Coding Sys--Orig (COC) ...................................................................................... 815 Morph Coding Sys--Current (NAACCR) .................................................................................................................. 816 Morph Coding Sys--Originl (NAACCR) .................................................................................................................... 817 Morph Coding Sys--Originl, Date of Diagnosis (COC) ............................................................................................ 819 Morphology--Type/Behavior ICDO3 (AZ) .............................................................................................................. 820 NAACCR Record Version (AZ) ................................................................................................................................ 826 NAACCR Record Version (NAACCR) ....................................................................................................................... 827 Name--Alias (SEER) ................................................................................................................................................ 829 Name--First (COC) .................................................................................................................................................. 830 Name--Last (COC) .................................................................................................................................................. 831 Name--Maiden (SEER) ........................................................................................................................................... 832 Name--Maiden, Check for Unknown (NAACCR) .................................................................................................... 833 Name--Middle (COC) ............................................................................................................................................. 834 Non-Reportable Skin ICDO3 (SEER IF117) ............................................................................................................. 835 NPI--Archive FIN (NAACCR) ................................................................................................................................... 836 NPI--Following Registry (NAACCR) ........................................................................................................................ 837 NPI--Physician--Follow-Up (NAACCR) .................................................................................................................... 838 NPI--Reporting Facility (NAACCR) .......................................................................................................................... 839


Page 13 of 1657

Obsolete Codes - CS Extension (CS) ....................................................................................................................... 840 Obsolete Codes - CS Lymph Nodes (CS) ................................................................................................................ 845 Obsolete Codes - CS Lymph Nodes Eval (CS) ......................................................................................................... 850 Obsolete Codes - CS Mets at DX (CS) ..................................................................................................................... 855 Obsolete Codes - CS Mets Eval (CS) ....................................................................................................................... 860 Obsolete Codes - CS Site-Specific Factor 1 (CS) ..................................................................................................... 865 Obsolete Codes - CS Site-Specific Factor 2 (CS) ..................................................................................................... 870 Obsolete Codes - CS Site-Specific Factor 3 (CS) ..................................................................................................... 875 Obsolete Codes - CS Site-Specific Factor 4 (CS) ..................................................................................................... 880 Obsolete Codes - CS Site-Specific Factor 5 (CS) ..................................................................................................... 885 Obsolete Codes - CS Site-Specific Factor 6 (CS) ..................................................................................................... 890 Obsolete Codes - CS Site-Specific Factor 7 (CS) ..................................................................................................... 895 Obsolete Codes - CS Site-Specific Factor 8 (CS) ..................................................................................................... 900 Obsolete Codes - CS Site-Specific Factor 9 (CS) ..................................................................................................... 905 Obsolete Codes - CS Site-Specific Factor10 (CS) .................................................................................................... 910 Obsolete Codes - CS Site-Specific Factor11 (CS) .................................................................................................... 915 Obsolete Codes - CS Site-Specific Factor12 (CS) .................................................................................................... 920 Obsolete Codes - CS Site-Specific Factor13 (CS) .................................................................................................... 925 Obsolete Codes - CS Site-Specific Factor15 (CS) .................................................................................................... 930 Obsolete Codes - CS Site-Specific Factor19 (CS) .................................................................................................... 935 Obsolete Codes - CS Site-Specific Factor21 (CS) .................................................................................................... 940 Obsolete Codes - CS Site-Specific Factor22 (CS) .................................................................................................... 945 Obsolete Codes - CS Site-Specific Factor23 (CS) .................................................................................................... 950 Obsolete Codes - CS Site-Specific Factor25 (CS) .................................................................................................... 955 Obsolete Codes - CS Tumor Size (CS)..................................................................................................................... 960 Obsolete Codes - CS Tumor Size/Ext Eval (CS) ...................................................................................................... 965 Obsolete Histology ICDO3, Date of DX (SEER) ....................................................................................................... 970 PhI Radiation Treatment Modality (COC) .............................................................................................................. 972 PhI Radiation Treatment Modality, Date DX (NAACCR) ........................................................................................ 974 PIN III ICDO3, Date of Diagnosis (SEER IF110) ....................................................................................................... 975 Place of Death--Country (NAACCR) ....................................................................................................................... 976 Place of Death--Country, Date of Diagnosis (NAACCR) ......................................................................................... 977 Place of Death--Country, Place of Death--State (NAACCR) ................................................................................... 979 Place of Death--Country, Vital Status (NPCR) ........................................................................................................ 981 Place of Death--State (NAACCR) ............................................................................................................................ 982 Place of Death--State, Date of Diagnosis (NAACCR) .............................................................................................. 983 Place of Death--State, Vital Status (NPCR) ............................................................................................................ 984 PR Summary, Breast, PR Percent (NAACCR) .......................................................................................................... 985 PR Summary, Breast, PR Percent, CoC Flag (SEER) ................................................................................................ 987 Primary Payer at DX (COC) .................................................................................................................................... 989 Primary Payer at DX (NPCR) .................................................................................................................................. 990 Primary Site (SEER SITE)......................................................................................................................................... 991 Primary Site, AJCC Stage Group 2016 - Ed 7 (COC)................................................................................................ 992 Primary Site, Behavior Code ICDO3 (SEER IF39) .................................................................................................. 1011 Primary Site, Heme Morph, DateDX, NoOverride (SEER) .................................................................................... 1013 Primary Site, Heme Morph, DateDX, Override (COC) ......................................................................................... 1017 Primary Site, Laterality (SEER IF82) ..................................................................................................................... 1019 Primary Site, M 2016 - Ed 7 (COC-NPCR) ............................................................................................................. 1021 Primary Site, Morphology-Imposs ICDO3 (SEER IF38) ......................................................................................... 1040


Page 14 of 1657

Primary Site, Morphology-Type ICDO3 (COC) ..................................................................................................... 1044 Primary Site, Morphology-Type,Beh ICDO3 (SEER IF25) ..................................................................................... 1048 Primary Site, N 2016 - Ed 7 (COC-NPCR) .............................................................................................................. 1052 Primary Site, Stage Group 2016 - Ed 7 (NPCR) .................................................................................................... 1071 Primary Site, T 2016 - Ed 7 (COC-NPCR) .............................................................................................................. 1090 Primary Site, TNM Clin Stage Valid A-Ed 7 (COC) ................................................................................................ 1110 Primary Site, TNM Clin Stage Valid B-Ed 7 (COC) ................................................................................................ 1117 Primary Site, TNM Path Stage Valid A-Ed 7 (COC) ............................................................................................... 1123 Primary Site, TNM Path Stage Valid B-Ed 7 (COC) ............................................................................................... 1130 Progesterone Receptor Summary, Date DX (NAACCR) ....................................................................................... 1137 Progesterone Receptor Summary, Schema ID, Required (NAACCR) ................................................................... 1139 PSA (Prostatic Specific Antigen) Lab Value, Date DX (NAACCR) .......................................................................... 1141 PSA (Prostatic Specific Antigen) Lab Value, Schema ID, Required (NAACCR) ..................................................... 1143 Race 1 (SEER RACE) .............................................................................................................................................. 1145 Race 1, Race 2, Race 3, Race 4, Race 5 (SEER IF93) ............................................................................................. 1146 Race 2 (NAACCR) ................................................................................................................................................. 1148 Race 2, Date of DX (SEER IF89) ............................................................................................................................ 1149 Race 3 (NAACCR) ................................................................................................................................................. 1150 Race 3, Date of DX (SEER IF90) ............................................................................................................................ 1151 Race 4 (NAACCR) ................................................................................................................................................. 1152 Race 4, Date of DX (SEER IF91) ............................................................................................................................ 1153 Race 5 (NAACCR) ................................................................................................................................................. 1154 Race 5, Date of DX (SEER IF92) ............................................................................................................................ 1155 Race Coding Sys--Curr, Race Coding Sys--Orig (COC) .......................................................................................... 1156 Race Coding Sys--Current (NAACCR) ................................................................................................................... 1157 Race Coding Sys--Original (NAACCR) ................................................................................................................... 1158 Rad--Regional RX Modality (COC) ........................................................................................................................ 1159 Rad--Regional RX Modality (NPCR) ...................................................................................................................... 1160 Rad--Regional RX Modality, Date of Diagnosis (COC) .......................................................................................... 1161 Rad--Regional RX Modality, Date of Diagnosis (NPCR) ........................................................................................ 1162 Rad--Regional RX Modality, Reason for No Rad (COC) ........................................................................................ 1164 Reason for No Radiation (NAACCR) ..................................................................................................................... 1165 Reason for No Radiation, Date of DX (NPCR) ...................................................................................................... 1166 Reason for No Radiation, PhI Radiation Treatment Modality (NAACCR) ............................................................ 1168 Reason for No Radiation, RX Date Radiation (COC) ............................................................................................ 1170 Reason for No Radiation, Vital Status (COC) ....................................................................................................... 1172 Reason for No Surgery (NPCR) ............................................................................................................................ 1173 Reason for No Surgery (SEER NCDSURG) ............................................................................................................ 1174 Reason for No Surgery, Date of DX (NPCR) ......................................................................................................... 1175 Reason for No Surgery, Vital Status (COC) .......................................................................................................... 1176 Record Type (NAACCR) ........................................................................................................................................ 1177 Recurrence Date--1st (COC) ................................................................................................................................ 1178 Recurrence Date--1st, Date 1st Crs RX COC (COC) .............................................................................................. 1180 Recurrence Date--1st, Date Flag (COC) ............................................................................................................... 1181 Recurrence Date--1st, Date Last Contact (COC) .................................................................................................. 1182 Recurrence Date--1st, Date of Diagnosis (COC) .................................................................................................. 1183 Recurrence Type--1st (COC) ................................................................................................................................ 1184 Recurrence Type--1st, Cancer Status (COC) ........................................................................................................ 1185 Recurrence Type--1st, Recurrence Date--1st (COC) ............................................................................................ 1186


Page 15 of 1657

Regional Nodes Ex, Reg Nodes Pos (COC) ........................................................................................................... 1187 Regional Nodes Examined (COC) ......................................................................................................................... 1189 Regional Nodes Examined (SEER) ........................................................................................................................ 1190

healthdata.az.govhealthdata.az.gov/az_edits/acr_v180_d1_descriptions.pdf · arizona cancer registry...

Documents